Literature DB >> 14663053

Skin biopsy in Lafora disease: genotype-phenotype correlations and diagnostic pitfalls.

D M Andrade1, C A Ackerley, T S C Minett, H A G Teive, S Bohlega, S W Scherer, B A Minassian.   

Abstract

Lafora disease is characterized by pathognomonic inclusions, Lafora bodies (LB), in neurons and other cell types. In skin, LB have been reported in either eccrine sweat glands or in apocrine sweat glands. The disease is caused by mutations in either the EPM2A gene or in a second yet-unknown gene. Here the authors determine whether a genotype-phenotype correlation exists between the genetic form of the disease and the skin cell type affected by LB formation. Also is described an important source of false positivity in the use of axillary biopsies for disease diagnosis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14663053     DOI: 10.1212/01.wnl.0000096017.19978.cb

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

Review 1.  Lafora disease: epidemiology, pathophysiology and management.

Authors:  Thomas S Monaghan; Norman Delanty
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 2.  Lafora disease, seizures and sugars.

Authors:  D M Andrade; J Turnbull; B A Minassian
Journal:  Acta Myol       Date:  2007-07

3.  Lafora bodies in skeletal muscle are fiber type specific.

Authors:  J Turnbull; J-M Girard; N Pencea; X Zhao; T E Graham; P Wang; C A Ackerley; B A Minassian
Journal:  Neurology       Date:  2011-03-30       Impact factor: 9.910

Review 4.  [Lafora disease: a review of the literature].

Authors:  L Desdentado; R Espert; P Sanz; J Tirapu-Ustarroz
Journal:  Rev Neurol       Date:  2019-01-16       Impact factor: 0.870

Review 5.  Lafora disease.

Authors:  Julie Turnbull; Erica Tiberia; Pasquale Striano; Pierre Genton; Stirling Carpenter; Cameron A Ackerley; Berge A Minassian
Journal:  Epileptic Disord       Date:  2016-09-01       Impact factor: 1.819

6.  Ocular phenotype and electroretinogram abnormalities in Lafora disease: A "window to the brain".

Authors:  Ajoy Vincent; Angelo Macrì; Anupreet Tumber; Nikolas Koukas; Saija Ahonen; Pasquale Striano; Berge Minassian
Journal:  Neurology       Date:  2018-06-15       Impact factor: 9.910

Review 7.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

8.  Early-onset Lafora body disease.

Authors:  Julie Turnbull; Jean-Marie Girard; Hannes Lohi; Elayne M Chan; Peixiang Wang; Erica Tiberia; Salah Omer; Mushtaq Ahmed; Christopher Bennett; Aruna Chakrabarty; Atul Tyagi; Yan Liu; Nela Pencea; XiaoChu Zhao; Stephen W Scherer; Cameron A Ackerley; Berge A Minassian
Journal:  Brain       Date:  2012-09       Impact factor: 13.501

Review 9.  Brain Glycogen Structure and Its Associated Proteins: Past, Present and Future.

Authors:  M Kathryn Brewer; Matthew S Gentry
Journal:  Adv Neurobiol       Date:  2019

10.  Novel mutation in the NHLRC1 gene in a Malian family with a severe phenotype of Lafora disease.

Authors:  M Traoré; G Landouré; W Motley; M Sangaré; K Meilleur; S Coulibaly; S Traoré; B Niaré; F Mochel; A La Pean; A Vortmeyer; H Mani; K H Fischbeck
Journal:  Neurogenetics       Date:  2009-03-26       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.